Evaluation of the two FVIII assay types (clotting and chromogenic) for measuring FVIII activity in cryoprecipitate

Abstract:
Background and ObjectivesIn Iran، cryoprecipitate is an important plasma product for coagulation factors such as factor VIII (FVIII) to be ensured. As risk of bleeding is associated with FVIII activity، it is important to choose a suitable method for its measurement. In the present study we compared clotting and chromogenic assays on FVIII activity in cryoprecipitate. Materials and MethodsFVIII activity of cryoprecipitate from 48 donors with different blood groups was measured by clotting and chromogenic assays. Then the two assay types were compared with each other. ResultsAlthough the absolute values showed a significant difference، a good correlation was seen between one-stage clot-based and chromogenic assays for measuring FVIII activity in cryo. ConclusionsAlthough the one-stage clotting assay is a suitable method for measuring FVIII activity، the chromogenic assay has a good correlation with clotting based assay. Also a significant difference was seen between the two methods.
Language:
Persian
Published:
Scientific Journal of Iranian Blood Transfusion Organization, Volume:8 Issue: 3, 2011
Page:
229
magiran.com/p912575  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!